MICAFUNGIN vs MIDOSTAURIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
MICAFUNGIN vs MIDOSTAURIN: Safety Overview
| Metric | MICAFUNGIN | MIDOSTAURIN |
|---|---|---|
| Total FAERS Reports | 3,117 | 2,993 |
| Deaths Reported | 1,068 | 694 |
| Death Rate | 34.3% | 23.2% |
| Hospitalizations | 1,121 | 918 |
| Average Patient Age | 49.7 yrs | 53.3 yrs |
| % Female Patients | 38.7% | 45.5% |
| FDA Approval Date | Apr 3, 2025 | Apr 28, 2017 |
| Manufacturer | Zydus Pharmaceuticals USA Inc. | Novartis Pharmaceuticals Corporation |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Discontinued | Prescription |